公开(公告)号：US20240091299A1

公开(公告)日：2024-03-21

申请号：US17947012

申请日：2022-09-16

申请人： The Hidden Vault LLC

发明人： Temeka Jones

IPC分类号： A61K36/9068 ,  A61K9/00 ,  A61K31/05 ,  A61K36/068 ,  A61K36/185 ,  A61K36/258 ,  A61K36/31 ,  A61K36/41 ,  A61K36/63 ,  A61K36/746 ,  A61K36/79 ,  A61K36/82 ,  A61K36/8962

CPC分类号： A61K36/9068 ,  A61K9/0034 ,  A61K31/05 ,  A61K36/068 ,  A61K36/185 ,  A61K36/258 ,  A61K36/31 ,  A61K36/41 ,  A61K36/63 ,  A61K36/746 ,  A61K36/79 ,  A61K36/82 ,  A61K36/8962

摘要： The present invention provides compositions formulated for topical administration to a penis of a person to enhance sexual responsiveness in the person, to enhance sexual performance, erection and stamina, and to increase the physical size of the penis, where the compositions comprise active components from herbal or plant origin including maca, tongkat ali, cordyceps, ginseng, fructus schisandrae. morinda root, rhodiola, rosea cordyceps sinensis, ginger, jasmine, sandalwood, leeks, camellia seed, jojoba oil and cannabidiol. The preferred composition is in the form of a massage oil, to be applied topically to the skin of the penis.

公开(公告)号：US11890311B1

公开(公告)日：2024-02-06

申请号：US17990637

申请日：2022-11-18

申请人： Bazelet Health Systems, Inc.

发明人： Michael Elzufon ,  Howard Hoffberg

IPC分类号： A61K36/185 ,  A61K31/05 ,  A61K31/16 ,  A61K36/9066 ,  A61K36/068

CPC分类号： A61K36/185 ,  A61K31/05 ,  A61K31/16 ,  A61K36/068 ,  A61K36/9066

摘要： A cannabinoid composition, comprising a full spectrum extract of a plant of genus cannabis comprising at least 5% by weight cannabigerol, comprising cannabis terpenes and cannabis flavonoids, and substantially without cannabidiol and tetrahydrocannabinol. The composition may be a pharmaceutically acceptable formulation for oral, sublingual, inhaled, vaporized, or smoked administration. The formulation may include absorption or pharmacological enhancers e.g., curcumin, resveratrol, quercitin, piperine and/or N-alkylamides. The composition has anti-inflammatory properties beneficial as a prophylaxis or therapy of symptoms due to SARS-Cov2 infection.

公开(公告)号：US20210077515A1

公开(公告)日：2021-03-18

申请号：US17105563

申请日：2020-11-26

申请人： Hangzhou Huadong Medicine Comprehensive Health Development Co., Ltd.

发明人： Bangliang LI ,  Caihong XU

IPC分类号： A61K31/706 ,  A61K36/068 ,  A61K47/38 ,  A61K47/12

摘要： The invention discloses a composition containing β-nicotinamide mononucleotide and Cordyceps sinensis. The ratio of β-nicotinamide mononucleotide to Cordyceps sinensis can be 2-5:1. The composition has the effects of improving NAD+ level in vivo, repairing DNA, maintaining cell health, promoting NADP synthesis, and increasing immunity. The combination of β-nicotinamide mononucleotide and Cordyceps sinensis can strengthen various effects, create synergistic effect, and thus the present composition is suitable for the majority of people.

公开(公告)号：US10537600B2

公开(公告)日：2020-01-21

申请号：US15698572

申请日：2017-09-07

申请人： JIANGZHONG PHARMACEUTICAL CO., LTD.

发明人： Hongguang Zhong ,  Minzhi Yi ,  Jianzhong Lu

IPC分类号： A61K36/00 ,  A61K36/074 ,  A61K9/16 ,  A61K9/48 ,  A61K36/068 ,  A61K36/258 ,  A61K36/344 ,  A61K36/481 ,  A61K36/738 ,  A61K36/896 ,  A61K36/8964

摘要： The present invention relates to a traditional Chinese medicine composition for regulating immunity and preparation method thereof, characterized in that the composition comprises raw materials such as Radix Panacis Quinquefolii, Ganoderma, fermented Cordyceps sinensis powder, Flos Rosae Rugosae, and Rhizoma Anemarrhenae and is prepared into various conventional pharmaceutical formulations through processes such as pulverization, water decoction and alcohol extraction. The traditional Chinese medicine composition is effective in preventing and treating allergic diseases, hepatitis B and AIDS, elevating leukocytes, preventing and treating radiation injury, reducing toxic and side effects resulting from radiotherapy and chemotherapy, improving the male sexual function, enhancing immunity of the human body and alleviating physical fatigue.

公开(公告)号：US10159705B2

公开(公告)日：2018-12-25

申请号：US13807097

申请日：2011-06-28

申请人： Christian Drapeau ,  Gitte S. Jensen

发明人： Christian Drapeau ,  Gitte S. Jensen

IPC分类号： A61K36/81 ,  A61K36/07 ,  A61K35/20 ,  A61K36/074 ,  A61K36/02 ,  A61K36/06 ,  A61K36/03 ,  A61K36/068 ,  A61K36/815 ,  A61K31/737 ,  A61K35/748

摘要： A method of using fucoidan to enhance stem cell mobilization in a subject, including hematopoietic stem cells (HSCs) and bone marrow stem cells (BMSCs) is provided. In the method, a blended composition of fruits, mushrooms, microorganisms, maternal fluids, and extracts thereof are used to promote trafficking of stem cells, resulting in migration of the stem cells to specific sties of maintenance an and repair within tissues and/or organs. The method also involves the use of fucoidan obtained from particular algae species to support release and circulation of HSCs, as demonstrated by significantly increase circulation of HSCs in the peripheral blood. Increased circulation of HSCs and/or BMSCs and migration towards sites of maintenance and the natural regeneration mechanisms in the body. Further provided is a dosing regimen for the administration of fucoidan and a method of enhancing release and circulation of stem cells.

公开(公告)号：US20180071273A1

公开(公告)日：2018-03-15

申请号：US15558928

申请日：2016-03-15

申请人： SPECCIALTY NUTRITION GROUP, INC.

发明人： Gregory T. Horn

IPC分类号： A61K31/455 ,  A23L33/105 ,  A23L33/15 ,  A61K31/09 ,  A61K31/14 ,  A61K31/385 ,  A61K31/706 ,  A61K36/068 ,  A61K36/258 ,  A61K36/28 ,  A61K36/38 ,  A61K36/53 ,  A61K36/54 ,  A61K36/87 ,  A61K36/9066

CPC分类号： A61K31/455 ,  A23L33/105 ,  A23L33/15 ,  A23V2002/00 ,  A23V2200/308 ,  A23V2250/0612 ,  A23V2250/21 ,  A23V2250/7046 ,  A61K31/09 ,  A61K31/14 ,  A61K31/385 ,  A61K31/706 ,  A61K36/068 ,  A61K36/258 ,  A61K36/28 ,  A61K36/38 ,  A61K36/53 ,  A61K36/54 ,  A61K36/87 ,  A61K36/9066 ,  A61K2300/00 ,  A23V2200/30

摘要： The present disclosure provides nutritional compositions comprising a synergistic effective amount of a NAD− pre-cursor in a combination with an ATP booster. ‘The disclosure provides methods and formulations to enhance natural energy. The disclosure also provides methods and formulations treat mitochondrial energy disorders or diseases.

公开(公告)号：US09623053B2

公开(公告)日：2017-04-18

申请号：US14438451

申请日：2013-12-31

申请人： Zhonglin Wang

发明人： Zhonglin Wang

IPC分类号： A61K36/068 ,  A61K36/8964 ,  A61K35/64 ,  A61K36/804 ,  A61K9/48 ,  A61K36/64 ,  A61K36/88

CPC分类号： A61K35/64 ,  A61K9/48 ,  A61K35/63 ,  A61K36/068 ,  A61K36/64 ,  A61K36/804 ,  A61K36/88 ,  A61K36/8964 ,  A61K2300/00

摘要： The present invention belongs to a pharmaceutical composition preparation field of traditional Chinese medicine, and more particularly relates to a pharmaceutical composition for treating AIDS and preparation method thereof. The pharmaceutical composition of the present invention for treating AIDS comprises the following raw medicinal materials: Cordyceps Sinensis in an amount of 3-6 parts by weight, Dried Radix Rehmanniae in an amount of 4-12 parts by weight, Mylabris in an amount of 1-3 parts by weight, and Rhizoma Anemarrhenae in an amount of 3-6 parts by weight. The clinical trials show that the pharmaceutical composition has a relatively good therapeutic effect for treating AIDS.

公开(公告)号：US09233134B2

公开(公告)日：2016-01-12

申请号：US14043014

申请日：2013-10-01

申请人： Jing Cheng ,  Chia-wen Chen ,  Steven Francis Schnittger ,  Ming Lu

发明人： Jing Cheng ,  Chia-wen Chen ,  Steven Francis Schnittger ,  Ming Lu

IPC分类号： A61K36/06 ,  A61K36/07 ,  A61K36/076 ,  A61K36/258 ,  A61K36/752 ,  A61K36/16 ,  A61K36/725 ,  A61K8/97 ,  A61K8/99 ,  A61Q19/00 ,  A61K36/756 ,  A61K36/804 ,  A61K36/8998 ,  A61K36/068 ,  A61K36/074 ,  A61K36/10 ,  A61K36/185 ,  A61K36/23 ,  A61K36/235 ,  A61K36/236 ,  A61K36/28 ,  A61K36/41 ,  A61K36/535 ,  A61K36/539 ,  A61K36/65 ,  A61K36/704 ,  A61K36/69

CPC分类号： A61K36/725 ,  A61K8/97 ,  A61K8/99 ,  A61K36/06 ,  A61K36/068 ,  A61K36/074 ,  A61K36/076 ,  A61K36/10 ,  A61K36/16 ,  A61K36/185 ,  A61K36/23 ,  A61K36/235 ,  A61K36/236 ,  A61K36/258 ,  A61K36/28 ,  A61K36/41 ,  A61K36/535 ,  A61K36/539 ,  A61K36/65 ,  A61K36/69 ,  A61K36/704 ,  A61K36/752 ,  A61K36/756 ,  A61K36/804 ,  A61K36/8998 ,  A61K2800/85 ,  A61Q19/00

摘要： The present invention relates to topical compositions containing fermented extracts of Traditional Chinese Medicinal (TCM) ingredients for improving the appearance and skin condition of the user. The topical compositions of the present invention are tailored for different users of different skin compositions according to TCM principles. The fermented TCM extracts are characterized by reduced odor and/or color in comparison with unfermented TCM extracts and are therefore more suitable for use in cosmetic products.

摘要翻译： 本发明涉及含有用于改善使用者的外观和皮肤状况的中药（TCM）成分的发酵提取物的局部组合物。 根据TCM原理，本发明的局部组合物针对不同皮肤组合物的不同使用者而定制。 与未发酵的TCM提取物相比，发酵的TCM提取物的特征在于减少气味和/或颜色，因此更适合用于化妆品。

公开(公告)号：US09161959B2

公开(公告)日：2015-10-20

申请号：US12451133

申请日：2008-04-28

申请人： Lieming Xu ,  Cheng Liu ,  Ping Liu

发明人： Lieming Xu ,  Cheng Liu ,  Ping Liu

IPC分类号： A61K36/068 ,  A61K36/537 ,  A61K36/424 ,  A61K36/79 ,  A61K36/15 ,  A61K36/53 ,  A61K36/57 ,  A61K36/73

CPC分类号： A61K36/424 ,  A61K36/068 ,  A61K36/15 ,  A61K36/53 ,  A61K36/57 ,  A61K36/73

摘要： Use of a vegetable drug composition in the manufacturing of a pharmaceutical preparation for the treatment of portal hypertension caused by hepatocirrhosis, said preparation comprises 25-38% of extract of radix Salviae Miltiorrhizae, 20-25% of extract of herb Gynostemmae Pentaphylli, 1-6% of alcoholic extract of fructus Schisandrae Chinensis, 19-26% of extract of Cordyceps, 6-8% of extract of pollen Pini, 6-10% of extract of semen Persicae. Said preparation can improve hepatic cell degeneration, necrosis, intraheptic hemorrhage, fiber proliferation, and reduce pressure of portal vein in mammal. A preparation method of said preparation is disclosed.

摘要翻译： 在制备用于治疗肝硬化引起的门静脉高压的药物制剂中使用植物药物组合物，所述制剂包含25-38％的丹参提取物，20-25％的绞股蓝草提取物，1- 6％的五味子酒精提取物，冬虫夏草提取物的19-26％，花粉皮尼提取物的6-8％，精液提取物的6-10％。 所述制剂可改善肝细胞变性，坏死，精神性出血，纤维增生，减轻哺乳动物门静脉压力。 公开了所述制备的制备方法。

公开(公告)号：US08986750B2

公开(公告)日：2015-03-24

申请号：US13824375

申请日：2011-09-16

申请人： Hongguang Zhong ,  Minzhi Yi ,  Jianzhong Lu ,  Yiguang Li ,  Li Ma ,  Yongjin Guo ,  Jinzhen Xu ,  Yibin Lv ,  Meixiang Yao

发明人： Hongguang Zhong ,  Minzhi Yi ,  Jianzhong Lu ,  Yiguang Li ,  Li Ma ,  Yongjin Guo ,  Jinzhen Xu ,  Yibin Lv ,  Meixiang Yao

IPC分类号： A61K36/00 ,  A61K36/074 ,  A61K36/738 ,  A61K36/068 ,  A61K36/258 ,  A61K36/344 ,  A61K36/36 ,  A61K36/43 ,  A61K36/481

CPC分类号： A61K36/258 ,  A61K36/068 ,  A61K36/074 ,  A61K36/344 ,  A61K36/36 ,  A61K36/43 ,  A61K36/481 ,  A61K36/738

摘要： The present invention provides a use of traditional Chinese medicine composition for manufacturing a health food or medicament for preventing and alleviating physical fatigue. The composition consists of 5-90 parts by weight of Radix Panacis Quinquefolii, 5-160 parts by weight of Ganoderma, 1-90 parts by weight of fermented Cordyceps sinensis powder and/or 1-120 parts by weight of Cordyceps, and these ingredients are made from Chinese crude drugs or from Chinese crude drug extracts in amounts equivalent to those of the Chinese crude drugs. The composition may further contain 5-90 parts by weight of Flos Rosae Rugosae. The present invention also relates to the use of said composition in the manufacture of prophylactic or therapeutic health foods or medicaments for reducing blood lipids, for resisting oxidation, and for enhancing anoxia endurance. The medicine composition of the present invention can be prepared into any conventional dosage forms by adding any pharmaceutically acceptable auxiliary agents.

摘要翻译： 本发明提供中药组合物用于制造用于预防和减轻身体疲劳的保健食品或药物的用途。 组合物由5-90重量份的甘草，5-160重量份的灵芝，1-90重量份的发酵的冬虫夏草粉和/或1-120重量份的冬虫夏草组成，这些成分 由中国生药或中国生药提取物制成，相当于中国生药。 组合物还可以含有5-90重量份的Flos Rosae Rugosae。 本发明还涉及所述组合物在制备用于减少血脂，抗氧化和增强缺氧耐力的预防或治疗保健食品或药物中的用途。 本发明的药物组合物可以通过添加任何药学上可接受的助剂来制备成任何常规剂型。